Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Cash & Current Investments (2021 - 2025)

Historic Cash & Current Investments for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to $9.4 million.

  • InMed Pharmaceuticals' Cash & Current Investments rose 6783.6% to $9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.4 million, marking a year-over-year increase of 6783.6%. This contributed to the annual value of $11.1 million for FY2025, which is 6809.98% up from last year.
  • InMed Pharmaceuticals' Cash & Current Investments amounted to $9.4 million in Q3 2025, which was up 6783.6% from $11.1 million recorded in Q2 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Cash & Current Investments peaked at $15.4 million during Q3 2021, and registered a low of $3.5 million during Q4 2024.
  • Over the past 5 years, InMed Pharmaceuticals' median Cash & Current Investments value was $9.0 million (recorded in 2023), while the average stood at $8.4 million.
  • In the last 5 years, InMed Pharmaceuticals' Cash & Current Investments plummeted by 6303.74% in 2024 and then surged by 6809.98% in 2025.
  • Quarter analysis of 5 years shows InMed Pharmaceuticals' Cash & Current Investments stood at $11.3 million in 2021, then rose by 1.5% to $11.5 million in 2022, then fell by 16.67% to $9.6 million in 2023, then plummeted by 63.04% to $3.5 million in 2024, then soared by 166.69% to $9.4 million in 2025.
  • Its Cash & Current Investments was $9.4 million in Q3 2025, compared to $11.1 million in Q2 2025 and $4.7 million in Q1 2025.